May 20, 2026 – Endologix LLC announced the acquisition of the Pounce™ Thrombectomy System from Surmodics, Inc.
The Pounce System is an FDA-cleared, fully mechanical thrombectomy system for the non-surgical removal of thrombi and emboli from peripheral arteries. Built around proprietary dual-basket technology and a nitinol collection funnel, the system is designed to support procedural simplicity, versatility, and efficiency without reliance on capital equipment, thrombolytics, or aspiration.
The platform includes multiple commercially available configurations: Pounce LP, Pounce, and Pounce XL, designed to support use across a range of peripheral arterial vessel sizes, including smaller and more distal vessels.
The Pounce Thrombectomy System will continue to be marketed in accordance with its existing FDA clearance during a transition period following the acquisition.